Mamantia, Rejane .

HRN: 23-58-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/31/2023
09/09/2023
IV
18mg As LD Then 9mg
Q12
Sepsis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: